LORI GRANT: Open Payments
NPI 1518954478 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 36 payments from 11 companies in 2025. Trend: 2023 $339 · 2024 $147 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $174 |
| Vanda Pharmaceuticals Inc. | 2 | $145 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Alkermes, Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $98 |
| Exact Sciences Corporation | 2 | $32 |
| Seqirus USA Inc | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, FANAPT, Qelbree, Auvelity, REXULTI, ARISTADA, The Cologuard Plus Collection Kit.
Industry payments across DE — which companies pay providers there.
